Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

VGQRX vs. RAGHX: which is better?

Bottom line

VGQRX vs RAGHX: the short answer

VGQRX (Virtus KAR Global Quality Dividend Fund) and RAGHX (Virtus KAR Health Sciences Fund) are both mutual funds.

RAGHX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

VGQRX vs RAGHX side by side

VGQRXRAGHX
TypeMutual fundMutual fund
Fund familyVirtusVirtus
CategoryDividend & Equity IncomeHealth Care Sector
Expense ratio—1.41%
Annual cost per $10k—$141
10-yr cost on $10k (prospectus)—$2,148
Max front load—5.5%
12b-1 fee—0.25%
1-yr return—+1.3%
5-yr return (annualized)—+2.4%
10-yr return (annualized)—+6.2%
Best quarter——
Worst quarter——
Net assets (fund)—$91.7M
Number of holdings—24
Portfolio turnover—13%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

VGQRX and RAGHX share none of their top holdings.

VGQRX top 10

    RAGHX top 10

    1. Eli Lilly & Company — 14.84%
    2. West Pharmaceutical Services Inc — 5.92%
    3. Abbvie Inc — 5.52%
    4. Vertex Pharmaceuticals Inc — 5.32%
    5. Merck & Company Inc — 5.06%
    6. Unitedhealth Group Inc — 4.65%
    7. Mckesson Corp — 4.57%
    8. Mettler-toledo International Inc — 3.99%
    9. Intuitive Surgical Inc — 3.89%
    10. Amgen Inc — 3.85%

    FAQ

    What is the difference between VGQRX and RAGHX?
    VGQRX (Virtus KAR Global Quality Dividend Fund) and RAGHX (Virtus KAR Health Sciences Fund) are both mutual funds. RAGHX has a front-end sales load of up to 5.5%; the other does not.
    Should I own both VGQRX and RAGHX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.